What is BRTX's dilution risk score?

BRTX has a latest available DilutionScore record of 77/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BRTX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BRTX?

DilutionWatch tracks 25 SEC filing types for BRTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BRTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BRTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BRTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BRTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BRTX Dilution Risk Score: 77/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

100

💰 Cash Runway

85

📊 Float Risk

12

⚠️ Warrant Exposure

50

🔄 Convertible Debt

15

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 62%

💰 Capital Raise model 73%

• Low cash runway: 4 months remaining

• Active shelf registration ($10M, 82% of market cap)

🔄 Reverse Split model est. 70%

• 50-day avg $0.25 below $1 exchange minimum

• Only 4 months cash — financial pressure

📜 Warrant Exercise model 25%

• Significant warrants: 18% of shares outstanding

🔔 Track BRTX — Get forecast alerts →

Market Data

Market Cap$12.18M

Shares Outstanding25.48M

Float24.18M

Cash$3.59M

Debt$153.7K

Short InterestN/A

Institutional Holdings

10 institutional holders · 677.1K shares

#1 Citadel Advisors Llc 238.6K shares

#2 Geode Capital Management, LLC 223.1K shares

#3 UBS Group AG 99.8K shares

+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest464.0K

Days to Cover1.1

% of Float1.9%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2021-12-31

424B3 ATM 2026-04-30

EFFECT EFFECT 2026-04-28

8-K 8K EVENT 2026-02-17

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual BRTX Dilution Snapshot

BioRestorative Therapies, Inc. (BRTX) has a DilutionScore of 77/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $10.0M.
Stored ATM program remaining capacity: $5.4M.
Stored outstanding warrants: 4.5M.
Recent SEC activity tracked for BRTX: 424B3 on 2026-04-30; EFFECT on 2026-04-28; 8-K on 2026-02-17.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.